- Home
- AKAN vs INM Comparison
AKAN vs INM Comparison
Compare AKAN & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKAN
- INM
- Stock Information
- Founded
- AKAN 2021
- INM 1981
- Country
- AKAN Canada
- INM Canada
- Employees
- AKAN N/A
- INM N/A
- Industry
- AKAN Medicinal Chemicals and Botanical Products
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- AKAN Health Care
- INM Health Care
- Exchange
- AKAN Nasdaq
- INM Nasdaq
- Market Cap
- AKAN 3.2M
- INM 3.2M
- IPO Year
- AKAN 2022
- INM N/A
- Fundamental
- Price
- AKAN $1.37
- INM $2.90
- Analyst Decision
- AKAN
- INM
- Analyst Count
- AKAN 0
- INM 0
- Target Price
- AKAN N/A
- INM N/A
- AVG Volume (30 Days)
- AKAN 63.6K
- INM 5.7M
- Earning Date
- AKAN 07-15-2025
- INM 05-12-2025
- Dividend Yield
- AKAN N/A
- INM N/A
- EPS Growth
- AKAN N/A
- INM N/A
- EPS
- AKAN N/A
- INM N/A
- Revenue
- AKAN $836,664.00
- INM $4,920,990.00
- Revenue This Year
- AKAN N/A
- INM N/A
- Revenue Next Year
- AKAN N/A
- INM N/A
- P/E Ratio
- AKAN N/A
- INM N/A
- Revenue Growth
- AKAN 97.47
- INM N/A
- 52 Week Low
- AKAN $0.93
- INM $1.72
- 52 Week High
- AKAN $5.08
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- AKAN 53.56
- INM 50.30
- Support Level
- AKAN $1.28
- INM $2.93
- Resistance Level
- AKAN $1.49
- INM $5.50
- Average True Range (ATR)
- AKAN 0.09
- INM 0.36
- MACD
- AKAN -0.00
- INM 0.01
- Stochastic Oscillator
- AKAN 57.89
- INM 22.22
About AKAN Akanda Corp.
Akanda Corp is a cannabis cultivation, manufacturing, and distribution company. The company has three reportable segments: Cultivation, Distribution, and Corporate. A majority of its revenue is generated from the Distribution segment, which relates to the distribution of medical cannabis products, including cannabis oil and cannabis flower for medical use in the United Kingdom.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.